CD45 Protein-Tyrosine Phosphatase Inhibitor Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|3|7|797-807

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.7, 2003-03, pp. : 797-807

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent discovery and development of protein tyrosine phosphatase inhibitors

By Kim Hwa-Ok   Blaskovich Mark A  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 871-905

Informa Healthcare

Access to resources Recommend Favorite

Protein-Tyrosine Phosphatase 1B as a Potential Drug Target for Obesity

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 299-304

Bentham Science Publishers

Access to resources Recommend Favorite

Asperentin B, a New Inhibitor of the Protein Tyrosine Phosphatase 1B

By Wiese Jutta   Aldemir Hülya   Schmaljohann Rolf   Gulder Tobias A. M.   Imhoff Johannes F.  

Marine Drugs, Vol. 15, Iss. 6, 2017-06 ,pp. : 191-191

MDPI

Access to resources Recommend Favorite

Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents

By  

Current Computer - Aided Drug Design, Vol. 14, Iss. 4, 2018-12 ,pp. : 349-362

Bentham Science Publishers

Access to resources Recommend Favorite

Yersinia pestis and Approaches to Targeting its Outer Protein H Protein-Tyrosine Phosphatase (YopH)

By  

Current Medicinal Chemistry, Vol. 19, Iss. 33, 2012-11 ,pp. : 5726-5734

Bentham Science Publishers

Access to resources Recommend Favorite